Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.87
+0.01000.54%
Post-market: 1.86-0.0095-0.51%19:30 EDT
Volume:2.35M
Turnover:4.32M
Market Cap:69.98M
PE:-1.27
High:1.91
Open:1.86
Low:1.80
Close:1.86
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:1.50
T/O Rate:13.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.62
PE(LYR):-1.39

Loading ...

Jun 02, 2020

Major Issues Report

8-K - Current report
May 18, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, item 2.03
Apr 29, 2020

Major Issues Report

Current report, item 3.01
Mar 30, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 13, 2020

Major Issues Report

Current report, items 1.01, 3.02, 7.01, and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 08, 2019

Major Issues Report

[Amend] Current report, item 5.07
Aug 30, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 14, 2019

Major Issues Report

Current report, item 5.07
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Dec 07, 2018

Correspondence

[Cover]Correspondence
Dec 07, 2018

Correspondence

[Cover]Correspondence